Vitamin D Regulation of Energy Metabolism in Cancer

作者: Dorothy Teegarden , Madeline P. Sheeley , Violet A. Kiesel , Chaylen Andolino

DOI: 10.1111/BPH.15424

关键词:

摘要: Vitamin D exerts anti-cancer effects in recent clinical trials and preclinical models. The actions of vitamin are primarily mediated through its hormonal form, 1,25-dihydroxyvitamin (1,25(OH)2 D). Previous literature describing vitro studies has predominantly focused on the anti-tumourigenic hormone, such as proliferation apoptosis. However, evidence identified 1,25(OH)2 a regulator energy metabolism cancer cells, where requirements for specific sources at different stages progression dramatically altered. suggests that regulates metabolism, including glucose, glutamine lipid during progression, well oxidative stress protection, it is closely associated with metabolism. Mechanisms involved regulation an emerging area which may inhibit multiple progression.

参考文章(140)
Gania Kessler-Icekson, Arthur Machlenkin, Ruth Koren, Carmela Rotem, Uri A. Liberman, Amiram Ravid, Dafna Rocker, Ayala Hochman, 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Research. ,vol. 59, pp. 862- 867 ,(1999)
Sydne J Newberry, Mei Chung, Paul G Shekelle, Marika Suttorp Booth, Jodi L Liu, Alicia Ruelaz Maher, Aneesa Motala, Mike Cui, Tanja Perry, Roberta Shanman, Ethan M Balk, Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) Evidence report/technology assessment. pp. 1- 929 ,(2014) , 10.23970/AHRQEPCERTA217
Vin Tangpricha, Michael F Holick, Tai C Chen, John N Flanagan, Tim Cordes, Jörg Reichrath, Michael Friedrich, Stefanie Becker, Dorle Fischer, Ingrid Gherson, Dagmar Diesing, Analysis of 25-Hydroxyvitamin D3-1α-Hydroxylase in Normal and Malignant Breast Tissue Anticancer Research. ,vol. 26, pp. 2615- 2620 ,(2006)
David R. Fraser, Vitamin D deficiency and energy metabolism. Endocrinology. ,vol. 156, pp. 1933- 1935 ,(2015) , 10.1210/EN.2015-1298
Heike Döppler, Peter Storz, Differences in Metabolic Programming Define the Site of Breast Cancer Cell Metastasis. Cell Metabolism. ,vol. 22, pp. 536- 537 ,(2015) , 10.1016/J.CMET.2015.09.022
Irit Hadari-Naor, Efrat Zuck, Ruth Koren, Carmela Rotem, Uri A. Liberman, Amiram Ravid, Vitamin D is a prooxidant in breast cancer cells. Cancer Research. ,vol. 61, pp. 1439- 1444 ,(2001)
Michael F. Holick, Vitamin D and Bone Health Journal of Nutrition. ,vol. 126, ,(1996) , 10.1093/JN/126.SUPPL_4.1159S
Roger Bouillon, Ine Beullens, Kathleen Marchal, Lieve Verlinden, Pierre De Clercq, Els Vanoirbeek, Guy Eelen, Suzanne Marcelis, Kristof Engelen, Bart De Moor, Annemieke Verstuyf, Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analog Anticancer Research. ,vol. 29, pp. 3585- 3590 ,(2009)
Christina Scheel, Robert A. Weinberg, Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Seminars in Cancer Biology. ,vol. 22, pp. 396- 403 ,(2012) , 10.1016/J.SEMCANCER.2012.04.001
Daniel D. Bikle, Extra Renal Synthesis of 1,25-dihydroxyvitamin D and its Health Implications Clinical Reviews in Bone and Mineral Metabolism. ,vol. 7, pp. 114- 125 ,(2009) , 10.1007/S12018-009-9033-Y